Patents
Zero-order
sustained release delivery system for carbamazepine derivatives. U.S. Pat. No.
6,296,873.
Anti-fungal
compositions with prolonged activity. U.S. Pat. No. 6,197,305.
Sustained release
formulation of carbamazepine. U.S. Pat. No. 6,162,466.
Synergistic herbal
extracts. U.S. Pat. No. 6,027,716.
Oral antifungal
preventative, and method of use. U.S. Pat. No. 5,989,522.
Zero-order
sustained release matrix tablet formulation of carbamazepine. U.S. Pat. No.
5,980,942.
Effervescent
granules. U.S. Pat. No. 5,948,439.
Local oral herbal
slow release tablets. U.S. Pat. No. 5,942,244.
Sustained-release
pharmaceutical system for the delivery of antioxidants. U.S. Pat. No. 5,897,879.
Dental composition
for hypersensitive teeth. U.S. Pat. No. 5,849,266.
Liquid polymer
composition, and method of use. U.S. Pat. No. 5,648,399.
Liquid polymer
composition, and method of use. U.S. Pat. No. 5,639,795.
Liquid polymer
composition, and method of use. U.S. Pat. No.5,438,076.
Dental composition
for hypersensitive teeth. U.S. Pat. No. 5,403,577.
Dental varnish
composition, and method of use. U.S. Pat. No. 5,330,746.
Liquid polymer
composition, and method of use. U.S. Pat. No. 5,160,737.
Dental composition
for hypersensitive teeth. U.S. Pat. No. 5,139,768.
Oral antifungal
preventative, and method of use. U.S. Pat. No. 5,116,603.
Sustained-release
pharmaceutical compositions. U.S. Pat. No. 5,023,082.
Compositions for
the sustained-release of chlorhexidine. U.S. Pat. No. 5,002,769.
Novel controlled
release dosage form of valproic acid. U.S. Pat. No. 4,913,906.
Sustained release
tablets of theophylline. U.S. Pat. No. 4,795,645.
